PXD015716 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Transformation of ibuprofen by Bacillus megaterium – Reversible glycosylation of the unhydroxylated drug and generation of hydroxylated and conjugated metabolites |
Description | Several pharmaceuticals persist in wastewater plants and contaminate increasingly natural water bodies, even ground water. In this study, different bacteria with known capabilities to degrade aromatic environmental pollutants – belonging to the genera Bacillus, Paenibacillus, Mycobacterium and Cupriavidus - were screened for their ability to transform the anti-inflammatory drug ibuprofen. Bacillus megaterium SBUG 518 as one of the most efficient strains tested was almost completely inhibited by 0.05% ibuprofen at pH 6 but was able to transform 0.005% ibuprofen within 4 h up to 92%. Four products were identified by HPLC and LC/MS. The drug was transformed via three different biotransformation reactions involving (A) conjugate formation of ibuprofen with a sugar molecule (B) the hydroxylation of the isobutyl side chain at two positions, and (C) glycosylation of 2-hydroxyibuprofen. The ibuprofen conjugate (ibuprofen pyranoside) was considerably less toxic to B. megaterium than the parent compound. Its reversible formation can lead to a temporary remarkable underestimation of ibuprofen concentrations in environmental “elimination” studies. Proteomic analyses including 1264 identified proteins suggest that cytochrome P450 BM3 plays a pivotal role in ibuprofen hydroxylation. Additionally, several proteins involved in stress response as well as proteins with similarity to multidrug efflux pump proteins were found in higher abundance in ibuprofen-incubated bacteria. |
HostingRepository | PRIDE |
AnnounceDate | 2025-04-14 |
AnnouncementXML | Submission_2025-04-14_07:16:48.984.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Tjorven Hinzke |
SpeciesList | scientific name: Bacillus megaterium; NCBI TaxID: 1404; |
ModificationList | monohydroxylated residue; acetylated residue |
Instrument | LTQ Orbitrap |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2019-10-07 01:41:06 | ID requested | |
⏵ 1 | 2025-04-14 07:16:49 | announced | |
Publication List
Keyword List
curator keyword: Biological |
submitter keyword: degradation,biodegradation, Bacillus subtilis, anti-inflammatory drugs (NSAIDs), micropollutants |
Contact List
Katharina Riedel |
contact affiliation | Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald |
contact email | riedela@uni-greifswald.de |
lab head | |
Tjorven Hinzke |
contact affiliation | University of Greifswald, Greifswald Intitute of Marine Biotechnology |
contact email | tjorven.hinzke@outlook.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/04/PXD015716 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD015716
- Label: PRIDE project
- Name: Transformation of ibuprofen by Bacillus megaterium – Reversible glycosylation of the unhydroxylated drug and generation of hydroxylated and conjugated metabolites